Skip to main content
. 2019 Sep 24;20(19):4724. doi: 10.3390/ijms20194724
AAZ acetazolamide
AD Alzheimer’s Disease
AEs anion exchangers
APP amyloid protein precursor
amyloid-β peptide
BBB blood-brain barrier
DS Down Syndrome
CA Carbonic Anhydrase
CAA Carbonic Anhydrase activator
CAI Carbonic Anhydrase inhibitor
CNS Central Nervous System
CO2 carbon dioxide
CP choroid plexuses
CytC cytochrome C
DS Down Syndrome
ELISA enzyme-linked immunosorbent assay
EPSP excitatory postsynaptic potential
ERK extracellular signal-regulated kinase
FDA Food And Drug Administration
GABA gamma-aminobutyric acid
HCO3- bicarbonate ion
HD Huntington’s disease
H2O2 hydrogen peroxide
i.p. Intraperitoneal
IPSP inhibitory postsynaptic potential
MCI mild cognitive impairment
MTZ Methazolamide
MWM Morris water maze
NINDS National Institute of Neurological Disorders and Stroke
NFTS neurofibrillary tangles
NMDA N-methyl-d-aspartate
OSA obstructive sleep apnoea
ROS reactive oxygen species
WHO World Health Organization
TgSwDI transgenic Swedish-Dutch-Iowa (mouse model of amyloidosis)
Tg65DN transgenic mouse model of Down Syndrome
ΔΨ mitochondrial membrane potential